Canadian Cancer Research Alliance honours Gerald Batist

November 8, 2019  —  Uncategorized
Dr. Gerald Batist is presented the CCRA Award for Exceptional Leadership in Cancer Research from co-chairs of the awards ceremony, Dr. Cindy Bell (left) of Genome Canada and Dr. Sara Urowitz (right) of CCRA and Canadian Partnership Against Cancer.Patrick Doyle, CP Images Patrick Doyle, CP Images

Dr. Gerald Batist, Director of the Segal Cancer Centre and Deputy Director of the Lady Davis Institute at the Jewish General Hospital, received the 2019 Award for Exceptional Leadership in Cancer Research from the Canadian Cancer Research Alliance (CCRA). Dr. Batist was one of individuals recognized by the CCRA “who have made a remarkable impact on cancer research and the cancer research community.”

In its citation, the CCRA praised Batist for “his decades-long commitment to accelerating the translation of new discoveries from the research laboratory into clinical benefits for cancer patients by building unique collaborative and multidisciplinary research programs and networks in Quebec, across Canada and internationally and addressing the major challenges in cancer research and cancer care.”

Dr. Rod McInnes, Director of the Lady Davis Institute, said, “Dr. Batist is one of Canada’s most outstanding cancer research leaders. This Award is a great recognition that honours not only Dr. Batist but the Lady Davis Institute and McGill University.”

Dr. Batist is a Professor of Oncology at McGill and Director of the McGill Centre for Translational Research in Cancer. His scientific focus is therapeutic resistance in cancer and the development of novel approaches to personalized medicine that offer each patient the most effectively targeted treatments for the active mutations that drive their disease.

Read the CCRA announcement

The post Canadian Cancer Research Alliance honours Gerald Batist appeared first on McGill Reporter.